Följ
Mikael Hoffmann
Mikael Hoffmann
NEPI, Linköping university
Verifierad e-postadress på nepi.net
Titel
Citeras av
Citeras av
År
The first decade with the Swedish prescribed drug register–a systematic review of the output in the scientific literature
SM Wallerstedt, B Wettermark, M Hoffmann
Basic & clinical pharmacology & toxicology 119 (5), 464-469, 2016
2212016
The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review
B Wettermark, H Zoëga, K Furu, M Korhonen, J Hallas, M Nørgaard, ...
Pharmacoepidemiology and drug safety 22 (7), 691-699, 2013
2032013
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ...
Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009
1842009
Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs
RE Malmström, BB Godman, E Diogene, C Baumgärtel, M Bennie, ...
Frontiers in pharmacology 4, 39, 2013
1192013
Changes in women's attitudes towards and use of hormone therapy after HERS and WHI
M Hoffmann, M Hammar, KI Kjellgren, L Lindh-Åstrand, J Brynhildsen
Maturitas 52 (1), 11-17, 2005
1042005
Women's conception of the menopausal transition–a qualitative study
L Lindh‐Åstrand, M Hoffmann, M Hammar, KI Kjellgren
Journal of Clinical Nursing 16 (3), 509-517, 2007
1032007
Pharmacokinetics of nicotine in kidney failure
L Molander, A Hansson, E Lunell, L Alainentalo, M Hoffmann, R Larsson
Clinical Pharmacology & Therapeutics 68 (3), 250-260, 2000
662000
High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden
HÅK Hanberger, M Hoffmann, S Lindgren, LE Nilsson
Scandinavian journal of infectious diseases 29 (6), 607-614, 1997
581997
14-year survey in a Swedish county reveals a pronounced increase in bloodstream infections (BSI). Comorbidity-an independent risk factor for both BSI and mortality
M Holmbom, CG Giske, M Fredrikson, Å Östholm Balkhed, C Claesson, ...
PLoS one 11 (11), e0166527, 2016
532016
Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in Sweden
B Pettersson, M Hoffmann, P Wändell, LÅ Levin
Health policy 104 (1), 84-91, 2012
462012
The prevalence of symptoms possibly related to the climacteric in pre-and postmenopausal women in Linköping, Sweden
C Jansson, S Johansson, L Lindh-Åstrand, M Hoffmann, M Hammar
Maturitas 45 (2), 129-135, 2003
412003
Attitudes towards the menopause and hormone therapy over the turn of the century
L Lindh-Åstrand, J Brynhildsen, M Hoffmann, S Liffner, M Hammar
Maturitas 56 (1), 12-20, 2007
372007
The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees
M Hoffmann
European journal of clinical pharmacology 69, 79-87, 2013
332013
Hot flushes, hormone therapy and alternative treatments: 30 years of experience from Sweden
L Lindh-Åstrand, M Hoffmann, M Hammar, AC Spetz Holm
Climacteric 18 (1), 53-62, 2015
322015
Hormone therapy might be underutilized in women with early menopause
L Lindh-Åstrand, M Hoffmann, L Järvstråt, M Fredriksson, M Hammar, ...
Human Reproduction 30 (4), 848-852, 2015
292015
Phases in development of an interactive mobile phone-based system to support self-management of hypertension
I Hallberg, C Taft, A Ranerup, U Bengtsson, M Hoffmann, S Höfer, ...
Integrated blood pressure control, 19-28, 2014
282014
Hormone replacement therapy in the menopause: Structure and content of risk talk
M Hoffmann, L Lindh-Åstrand, J Ahlner, M Hammar, KI Kjellgren
Maturitas 50 (1), 8-18, 2005
252005
Generic pregabalin: current situation and implications for health authorities, generics and biosimilars manufacturers in the future
B Godman, M Wilcock, A Martin, S Bryson, C Baumgärtel, T Bochenek, ...
Generics and Biosimilars Initiative Journal 4 (3), 125-135, 2015
242015
Risk talk: rhetorical strategies in consultations on hormone replacement therapy
M Hoffmann, P Linell, L Lindh-Åstrand, K Kjellgren
Health, Risk & Society 5 (2), 139-154, 2003
232003
Surveillance of antibiotic resistance in ICUs in southeastern Sweden
CM Erlandsson, H Hanberger, I Eliasson, M Hoffmann, B Isaksson, ...
Acta anaesthesiologica scandinavica 43 (8), 815-820, 1999
221999
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20